1. Home
  2. NBTX vs NFE Comparison

NBTX vs NFE Comparison

Compare NBTX & NFE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NBTX
  • NFE
  • Stock Information
  • Founded
  • NBTX 2003
  • NFE 2014
  • Country
  • NBTX France
  • NFE United States
  • Employees
  • NBTX N/A
  • NFE N/A
  • Industry
  • NBTX Biotechnology: Pharmaceutical Preparations
  • NFE Oil/Gas Transmission
  • Sector
  • NBTX Health Care
  • NFE Utilities
  • Exchange
  • NBTX Nasdaq
  • NFE Nasdaq
  • Market Cap
  • NBTX 868.8M
  • NFE 773.2M
  • IPO Year
  • NBTX 2020
  • NFE 2019
  • Fundamental
  • Price
  • NBTX $21.04
  • NFE $2.29
  • Analyst Decision
  • NBTX Strong Buy
  • NFE Strong Buy
  • Analyst Count
  • NBTX 1
  • NFE 5
  • Target Price
  • NBTX $8.00
  • NFE $7.70
  • AVG Volume (30 Days)
  • NBTX 112.7K
  • NFE 29.8M
  • Earning Date
  • NBTX 09-30-2025
  • NFE 11-06-2025
  • Dividend Yield
  • NBTX N/A
  • NFE N/A
  • EPS Growth
  • NBTX N/A
  • NFE N/A
  • EPS
  • NBTX N/A
  • NFE N/A
  • Revenue
  • NBTX $11,930,711.00
  • NFE $2,006,240,000.00
  • Revenue This Year
  • NBTX N/A
  • NFE $10.40
  • Revenue Next Year
  • NBTX $74.67
  • NFE $11.08
  • P/E Ratio
  • NBTX N/A
  • NFE N/A
  • Revenue Growth
  • NBTX N/A
  • NFE N/A
  • 52 Week Low
  • NBTX $2.76
  • NFE $1.26
  • 52 Week High
  • NBTX $22.51
  • NFE $16.66
  • Technical
  • Relative Strength Index (RSI)
  • NBTX 71.69
  • NFE 47.78
  • Support Level
  • NBTX $19.11
  • NFE $2.10
  • Resistance Level
  • NBTX $22.64
  • NFE $2.66
  • Average True Range (ATR)
  • NBTX 1.64
  • NFE 0.33
  • MACD
  • NBTX 0.63
  • NFE 0.03
  • Stochastic Oscillator
  • NBTX 83.03
  • NFE 26.58

About NBTX Nanobiotix S.A.

Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.

About NFE New Fortress Energy Inc.

New Fortress Energy Inc is an integrated gas-to-power company. Its business model spans the entire production and delivery chain from natural gas procurement and liquefaction to logistics, shipping, terminals, and conversion or development of a natural gas-fired generation. It has invested in floating, liquefied natural gas vessels to lower the cost of acquiring gas while securing a long-term supply for its terminals. Its segments include Terminals & Infrastructure, and Ships. It generates the majority of its revenue from the Terminals & Infrastructure segment.

Share on Social Networks: